Ignite Creation Date:
2025-12-25 @ 1:34 AM
Ignite Modification Date:
2025-12-28 @ 12:05 AM
Study NCT ID:
NCT00588094
Status:
COMPLETED
Last Update Posted:
2015-12-04
First Post:
2007-12-26
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Dose Augmented Rituximab and ICE for Pts With Primary Refractory and Poor Risk Relapsed Aggressive B-Cell NHL
Sponsor:
Memorial Sloan Kettering Cancer Center
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2003-10
Start Date Type:
None
Primary Completion Date:
2010-03
Primary Completion Date Type:
ACTUAL
Completion Date:
2010-03
Completion Date Type:
ACTUAL
First Submit Date:
2007-12-26
First Submit QC Date:
None
Study First Post Date:
2008-01-08
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2015-10-27
Results First Submit QC Date:
None
Results First Post Date:
2015-12-04
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2015-10-27
Last Update Post Date:
2015-12-04
Last Update Post Date Type:
ESTIMATED